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Lactadherin, as one of the immune components in the breast milk, might play a role in the intestinal immune system of
newborn. Therefore, we investigated the eﬀect of lactadherin-feeding in early time on the development of intestinal immune
system compared with naturally rearing and artiﬁcially rearing (non-lactadherin). In the present study, we observed that the
Peyer’s Patches (PP) from the pups of artiﬁcially reared group with lactadherin added were characterized by an excess of
OX62+CD4+SIRP+ DC cells and a higher expression of CD3+CD4+CD25+T cells. Additionally, this study also demonstrated
that IL-10 production was dramatically increased when lactadherin was present in culture medium compared with lactadherin-
absent culture. These results suggested that lactadherin could adjust intestinal DCs activity, induce CD3+CD4+CD25+Tc e l l
diﬀerentiation, and enhance IL-10 production.
1.Introduction
A relationship between breast-feeding and infant health
particularly the health of the gastrointestinal tract had
been recorded periodically for thousands of years across
many disparate civilizations [1]. As early as in 1934, a
report on 20,000 mother-infant dyads in the United States
found that morbidity or mortality caused by enteric disease
was several times higher in nonbreast-fed infants than in
breast-fed infants [2]. These diﬀerences suggest that human
milk has protective activities which are lacked in even the
best artiﬁcial formulas. Recent reports associate artiﬁcial
feeding of neonates with subsequent chronic diseases in later
life, especially those with an immune component [3]. The
mechanism has not yet been well characterized, but it could
be contributed by three major phenomena. First, Human
milk accelerates maturation of the gut barrier function
while formula does not [4–6]. Second, the neonate may
be protected from pathogenic insults during this vulnerable
period by bioactive components of human milk [7]. Third,
human milk components could actively adjust early immune
reactions or stimulate the immune response system by
activating immune factors.
When the infant is exposed to a novel enteric pathogen,
the pathogen will be presented to the dendritic cells (DCs)
to subsequence T lymphocytes activity and B lymphocytes
stimulation either locally in the Peyer’s Patch (PP) or after
migration to the mesenteric or other lymph nodes [8].
Nutrition may be the source of the immune system
tolerant food antigens. Nutrients might modulate immune
maturation and responses, and provide factors that inﬂuence
intestinal ﬂora. Through these mechanisms, it is possible
that nutrition in early life might aﬀect later immune
competence, the ability to mount an appropriate immune
response upon infection, the ability to develop a tolerogenic
responseto“self”andtobenignenvironmentalantigens,and
the development of immunologic disorders [9]. However,
accurate components in human milk that accelerated the
evolution of the intestinal immune system in infants remain
unknown.2 Clinical and Developmental Immunology
Lactadherin is an MW 47,000 glycoprotein in milk fat
globules. It has also been known as PAS-6/7 which indicates
two glycosylation variants [10], bovine-associated muco-
protein, BA-46, P47, and MFG-E8 [11]. Lactadherin has a
domain structure of EGF1–EGF2–C1–C2. EGF-like domain
indicates epidermal growth factor homology domain. And
the C-terminal domain shares homology with the discoidin
family including the lipid-binding domains of blood coag-
ulation factor VIII and factor V [10]. The second EGF-like
domain displays an Arg–gly–Asp motif [12], which binds to
the avβ5a n da v β3 integrins [10, 13–16]. And a variety of
immune-relatedcellssuchas,macrophagesandDCshavethe
corresponding integrin receptors on the cell surface.
It was reported that the levels of lactadherin in 41 human
milk samples of 20 mothers were 93 ± 10μg/mL [17]. The
amount of lactadherin was signiﬁcantly higher in early milk
samples (<15 d postpartum) than in later milk samples
(15–90d postpartum). Signiﬁcant amounts of lactadherin
were found in almost all gastric aspirates of human milk-
fed infants, even 4 hours after feeding (23.2 ± 4.4 μg/mL).
Westernblot analysisdemonstrated that the immunoreactive
lactadherin in the milk-fed gastric aspirates had the expected
native molecular weights. There are few studies that have
evaluated the role of lactadherin in the intestine immune
system, which adjusts early immune reactions and stimulates
the immune response system.
Our aim in this study was to investigate the role of the
lactadherin in the intestine immune system by comparing
among breast-fed rats, artiﬁcial-fed rats, and lactadherin-
rich-fed rats. We performed artiﬁcial rearing during the
suckling period with a reﬁned formula that was made to
resemble rat milk. We compared in detail the development
of intestine system during suckling and weaning among the
three groups.
2.MaterialsandMethods
2.1.Animals. SDratswerepurchasedfromShanghaiLabora-
toryAnimalCenter(ChineseAcademyofSciences,Shanghai,
China). All rats were held in the sterile plastic cages in
temperature- and humidity-controlled animal rooms under
a12-hourlight/darkcyclecondition.Ratswerefedastandard
diet (rodent rat chow) ad libitum with free access to tap
water. All procedures were approved by the Institutional
Animal Care Committee. Three days after birth, the rat
pups were weighed and randomly assigned to three groups.
In the ﬁrst group, 10 rat pups were reared by one of
their mothers throughout the entire suckling period (breast
milk-reared group, BR group). In the second group, an
intragastric cannula was implanted through esophageal at
the 7th day after birth using the method of Hall [18], and
the rat pups were then artiﬁcially reared the formula milk
without lactadherin (artiﬁcially-reared group, AR group) till
the suckling period. In the third group, the same surgery was
performed on the rat pups at the same day as in AR group.
The rat pups were then artiﬁcially reared the formula milk
with lactadherin of 100μg/ml (artiﬁcially-reared group with
lactadherin added, LR group) till the suckling period, and
Table 1:Nutrientcompositionandphysicalpropertiesofrat’smilk.
Nutrient (weight/100mL) Formula Rat milk
Protein (g) 9.00 10.5 ± 1.5
Whey 3.6 3.5 ± 0.5
Casin 5.4 7.0 ± 4.8
Carbohydrate (g) 2.5 2.0 ± 1.0
Fat (g) 12 11.4 ± 4.8
Minerals (mg)
Calcium 315 379 ± 43
Potassium 122 83 ± 19
Chloride 160 140 ± 16
Magnesium 21 22 ± 1
Vitamins
Vitamin A (IU) 215.2
Vitamin D3 (IU) 35
Energy content (Kj/100mL milk) 637.0 632.0 ± 235.0
Osmolarity (mOsm/kg H2O) 343 ± 12 352 ± 5
pH 6.5 ± 0.1 6.5 ± 0.1
then the cannula was removed immediately. The pups were
subsequently returned to one of their mothers and reared
with breast milk throughout the suckling period.
2.2. Artiﬁcial Rearing of Rats. The milk formula used for the
AR rat pups was prepared by the method of Kanno et al.
[19]under aseptic conditions, and its composition is shown
in Table 1.K a n n oe ta l .[ 19] prepared a reﬁned formula, the
composition of which closely resembled that of rat milk. The
formula was dispensed into 50-mL sterilized polypropylene
bottles, and stored frozen at 40
◦C. The osmotic pressure
and pH of the formula milk were 343 and 6.5, respectively.
The frozen formula was sterilized by gamma ray irradiation
(30kGy).
The volume of formula administered was adjusted daily
according to the growth of the AR rat pups in comparison
with the MR rat pups and was increased from 2.7mL/d on
day 4 to 8.2mL/d on day 21. The rat pups were excluded
when the cannula fell oﬀ during artiﬁcial rearing.
2.3. Reagents. Mouse antirat OX62:RPE (clone OX-62),
mouse antirat CD172a:FITC (clone OX-41), mouse anti
rat CD4:APC (clone W3/25), mouse antirat CD3:FITC
(clone KT3), mouse antirat CD4:PE-Cy5 (clone RM4-5),
mouse antirat CD8-APC (clone OX-8), and mouse antirat
CD25:PE (clone IF4/OX-39/OX-6) were purchased from
Serotec (Raleigh, NC, USA).
ELISA kits of IL-10 (clone no. 31052) and IL-12 (P70
clone no. 127107) were purchased from BD Biosciences (San
Jose, CA).
2.4. Tissue Samples. Rats were euthanized at postpartum
age of 21 days, 35 days, 49 days, 63 days, and 77 days.
Abdominalcavitieswereopenedbyhorizontalincisionalong
the midsection and guts were excised. Central ileum tissue
samples (0.5cm) were taken.Clinical and Developmental Immunology 3
2.5. Flow Cytometry. PP tissue samples were washed 3 times
in cold PBS. They were then cut into small segments and
placed in cold PBS (4◦C). After centrifugation at 800rpm
for 5 minutes at 4◦C, the supernatant was discarded and the
remainingtissuesweredigestedwith0.75mg/mLcollagenase
Af o r4 5m i n u t e sa t3 7
◦C with gentle rock. Undigested
stoma material was removed by passing over ﬁltration.
Single-cell suspension was mashed through a cell strainer,
washedoncewithPBScontaining2%FCSand10mMEDTA
(staining buﬀer) before FACS analysis. Cells were incubated
with mouse antirat OX62: RPE, mouse antirat CD172a:
FITC (OX41), mouse antiratCD4: APC, mouse antirat CD3:
FITC, mouse antirat CD4: PE-Cy5, mouse antirat CD8-
APC, and mouse antirat CD25: PE, respectively. Staining
was performed in staining buﬀer for 30 minutes on ice
after blocking for 30 minutes. The cells were ﬁxed in 2%
paraformaldehyde before analyzed with an FACS Calibur
(BD Biosciences).
2.6. Cell Puriﬁcation and Culture. Human cord blood
monocyte-derived DCs were prepared based upon standard
techniques [20]. The study was approved by the Shanghai
Ethical Committee of Human Genetic Resources and all
subjects gave informed consent for examinations. Brieﬂy,
30mL of fresh human cord blood were collected in sodium
heparin vacutainer collection tubes (BD Biosciences) from
volunteers. The blood was diluted with PBS in an endo-
toxinfree bottle at a 1:2 ratio. CBMC were separated using
Ficoll-PaquePlusatroomtemperatureandwashedwithPBS.
Monocytes were cultured (1×106 perwell)for1hourat37
◦C
followed by the removal of nonadherent cells; monocytes
puriﬁed were >80% pure as determined by ﬂow cytometry
(datanotshown).Thesecells(1to2×104/mL)werecultured
for 7 days in 6-well plates in humidiﬁed 5% CO2 at 37
◦C,
in RPMI 1640, 10% heat-inactivated fetal calf serum (FCS),
1% glutamine, 100U/mL penicillin, and 100Ug/mL strep-
tomycin, with 50ng/mL recombinant human granulocyte-
macrophage colony-stimulating factor (GM-CSF), 10ng/mL
interleukin (IL)-4, as described. Thereafter, cells were further
cultured with GM-CSF and IL-4 to establish diﬀerentiation
to DC phenotype, with or without lactadherin (0.5Ug /mL)
present. Medium and cytokines were renewed every 3 days.
To induce maturation of DCs, 50ng/mL tumor necrosis
factor (TNF-a) was added to cultures on day 5.
2.7. Measurement of Cytokine Release. To detect cytokine
secretion, after 7 days of culture, 105 monocyte-derived DC
per well supernatants were frozen at −80
◦C until assayed
for cytokines by ELISA. Cytokine levels in supernatants were
measured in triplicate with human IL-10 and human IL-12
ELISA kits.
2.8. Statistical Analysis. SPSS 11.0 statistical software was
used for data analysis. Results were showed as mean val-
ues with standard deviation (SD). Statistical analysis was
completed using one-way ANOVA. Tukey’s test was used to
determine the diﬀerence among groups when the ANOVA
test indicated a signiﬁcant eﬀect. P values <. 05 were
considered statistically signiﬁcant.
3. Results
There were no signiﬁcant diﬀerences in either the body
weight or gain in body weight throughout the suckling
period and after weaning among the three groups.
3.1. Ontogeny Analysis of PP-DCs. Figure 1 and Table 2
showed the development of DCs in the PPs of MR, AR, and
LR rat pups during suckling and after weaning. We observed
age-dependent changes of DCs in three groups. Single-cell
suspensions of the total PP-DCs in rats were identiﬁed
by OX62 staining. As shown in Figure 1(a), the expression
of OX62+DC (i.e., the total PP-DC) increased with age
in all three groups. However, no signiﬁcant diﬀerence of
OX62+DC expression among the three groups was observed
(F = 3.0, 0.587, 3. 267, 1.471; P>. 05, Table 2), regardless of
the development stages.
With containing two populations distinguished by
coexpression of CD4 and SIRPα or neither, signiﬁcant
numbers of OX62+CD4+SIRP+DCs were detected in LR
group as early as 3 weeks of age. Furthermore, the
OX62+CD4+SIRP+DCs were higher in LR group than
in BR group. The OX62+CD4+SIRP+DCs kept stable
in LR group while the positive cells number increased
with age in the other 2 groups. Signiﬁcant numbers of
OX62+CD4+SIRP+DCswereobservedinLRandBRgroupat
various ages (Table 3, Figures 1(b) and 1(c)) compared with
AR group.
3.2. Ontogeny Analysis of PP-T-Cells. Table 4 showed the
number of the CD3+T cells in MR, AR, and LR rat pups.
There was no diﬀerence in either value among the three
groups. The CD3+CD4+ T cells (Table 5) did not diﬀer
among the MR, AR, and LR rat pups (except at age week
5), but the number of the CD3+CD4+CD25+ Tc e l l si n
the PP was signiﬁcantly higher in the LR rats than the
M Ra n dA Rr a t s( Table 6 and Figure 2). The number of
CD3+CD4+CD25+ T cells in the GR group was values in
between those of the other two groups. The CD3+CD4+ T
cells in GR group were also values in between those of the
others,althoughtherewerenotsigniﬁcantlydiﬀerent(except
at age week 5).
CD3+CD4+CD25+ T-cells play an important role
in immunosuppression. As shown in our present
study, lactadherin induces CD4+ Tc e l lt od i ﬀerentiate
CD3+CD4+CD25+. To address whether lactadherin could
induce the cytokine secretion of PP DCs, we compared
IL-10 and IL-12 production levels in an in vitro culture
system. IL-12 production has no signiﬁcant diﬀerence with
or without lactadherin present in the culture medium.
Interestingly, IL-10 production was dramatically increased
when lactadherin was present in culture medium compared
with that of lactadherin absent culture (Figure 3).4 Clinical and Developmental Immunology
Table 2: The express level of the OX62+ intestinal DC of each group in diﬀerent development stage (Mean±S) (N = 5).
BR AR LR FP
3w 0.33 ± 0.06 0.23 ± 0.06 0.33 ± 0.06 3.00 .125
5w 0.37 ± 0.12 0.43 ± 0.06 0.50 ± 0.17 0.86 .471
7w 0.47 ± 0.15 0.73 ± 0.06 0.63 ± 0.15 3.27 .110
11w 0.80 ± 0.17 0.63 ± 0.15 0.63 ± 0.05 1.47 .302
Table 3: The express level of the OX62+CD4+SIRP+intestinal DC of each group in diﬀerent development stages (Mean±SD) (N = 5).
BR AR LR FP
3w 32.53 ± 0.86 26.5 ± 1.3 43.7 ± 1.57 140.55 .000
5w 30.73 ± 5.17 29.93 ± 3.2 43.73 ± 1.57 13.72 .006
7w 35.50 ± 4.08 33.70 ± 2.87 46.10 ± 6.58 5.92 .038
11w 43.60 ± 2.07 36.57 ± 0.96 46.80 ± 5.49 6.97 .027
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Figure 1: The expression of OX62+DCs and OX62+CD4+SIRP+DCs of each groups at various development stages (Mean±SD). (a) The
expression level of OX62+DCs of each group at diﬀerent stages. (b) The expression level of OX62+CD4+SIRP+ DCs of each group at diﬀerent
stages. (c) Single-cell suspensions of the total PP-DCs in rats were identiﬁed by OX62. The diﬀerence of OX62+DC among groups at diﬀerent
development stages was not signiﬁcant. (F = 3.0, 0.587, 3.267, and 1.471, resp.; P>. 05). Signiﬁcant growth occurred in LR group for the
number of OX62+CD4+SIRP+DCs at age week 3. Levels of OX62+CD4+SIRP+DC subsets at every age were highly signiﬁcant in LR group
and BR group compared with AR group. Furthermore, the positive cell numbers were higher in LR group than in BR group. The positive
cell numbers kept stable in LR group at various ages while the positive cells number increased with age in the other two groups. Signiﬁcant
numbers of OX62+CD4+SIRP+DCs were found in LR and BR group at various ages (Figures 1(b) and 1(c)) compared with AR group (A: BR
at W3, B: AR at W3, C: LR at W3, D: BR at W5, E: AR at W5, F: LR at W5, G: BR at W7, H: AR at W7, I: LR at W7, J: BR at W11, K: AR at
W11, L: LR at W11). ∗P<. 05.Clinical and Developmental Immunology 5
Table 4: The express level of the CD3+ T cells of each group in diﬀerent development stage (Mean±SD) (N = 5).
BR AR LR F P
3w 11.23 ± 0.58 9.13 ± 3.32 19.36 ± 2.27 15.89 .004
5w 23.33 ± 3.13 19.33 ± 0.77 21.16 ± 3.11 1.79 .245
7w 20.40 ± 4.39 29.66 ± 4.04 23.93 ± 3.48 4.12 .075
11w 23.83 ± 4.56 28.76 ± 0.58 25.40 ± 3.20 1.81 .242
Table 5: The express level of the CD3+ CD4+ T cells of each group in diﬀerent development stage (Mean±SD) (N = 5).
BR AR LR F P
3w 34.67 ± 8.04 31.73 ± 1.78 32.03 ± 2.88 0.30 .746
5w 51.36 ± 6.43 47.36 ± 7.99 63.91 ± 4.13 5.71 .041
7w 53.80 ± 12.15 61.16 ± 7.05 47.10 ± 6.75 1.83 .239
11w 52.03 ± 5.65 57.20 ± 2.55 49.66 ± 5.50 1.94 .224
Table 6: The express level of the CD3+ CD4+ CD25+ T cells of each group in diﬀerent development stage (Mean±SD) (N = 5).
BR AR LR FP
3w 14.40 ± 2.30 5.50 ± 0.26 15.83 ± 1.15 41.89 .000
5w 5.76 ± 0.66 6.80 ± 0.10 11.83 ± 0.49 119.03 .000
7w 8.53 ± 1.91 7.13 ± 0.46 10.46 ± 1.45 4.20 .072
11w 9.50 ± 1.11 8.63 ± 0.57 12.73 ± 1.91 27.18 .001
4. Discussion
Oshima et al. [21] indicated that lactadherin mRNA has
previously been shown to be in the gut. However, it is
still largely unknown how lactadherin functions in the
intestine in vivo. Heng-Fu et al. [22] studied the role of
lactadherin in maintenance and repair of murine intestine
in vivo. They indicated that lactadherin played an important
role in the maintenance of intestinal epithelial homeostasis.
Components such as lactadherin, lactoferrin, and epidermal
growth factor (EGF) are contained in maternal milk. The
neonate takes these components from maternal milk, as
the neonate itself cannot yet produce them in the same
levels as healthy adults [23]. Spadaro et al. [24] elucidated
that lactoferrin induced the maturation of human DCs and
by function (cytokine production, loss of antigen internal-
ization, and induction of T cell response). Stepankova et
al. [25] elucidated that addition of EGF to diet increased
the CD4+ T cells. PPs are typical gut-associated lymphoid
tissues located along the small intestine wall and serve as
the major sites for generation of immunity to intestinal
antigens [26]. DCs are the most potent antigen-presenting
cells for activation of further immune responses. Speciﬁcally,
intestinal DCs can result in immune response limited to the
intestinal mucosa without stimulating the whole immune
system. Thus, intestinal DCs, one of the best characters
representing the maturation and activation of intestinal
mucosal immunity [27], can exist in diﬀerent levels of
maturation and activation that are reﬂected in diﬀerent
ways, including antigen capture and processing, eﬀector cell
activation, and cytokine networking. A subpopulation of
CD4+ T cells that coexpress CD25 (the a-chain of IL-2R)
with regulatory function has been identiﬁed in the mucosa,
and has been reported to be generated by the exposure of
intestinal immune system to luminal antigens. These cells
appear to play an important role in the induction and
maintenance of immune tolerance in the normal intestine
[28]. Therefore, it can be questioned if lactadherin, one
of the immune components in the breast milk, aﬀects the
immune cells compositions in PP. In order to answer this
question, we designed this experiment to evaluate the eﬀect
of lactadherin function in the development of intestinal DCs
and T cells. In our experiment, we developed and char-
acterized a rat model of artiﬁcial feeding, which possesses
almost all important biological similarities to the formula
milk feeding human infant except for the lactadherin, as a
negative control group. We observed that LG pups exhibited
an excess of PP in the gut (data not shown). PPs from
the pups of LR were characterized by a higher expres-
sion of OX62+CD4+SIRP+ DCs and CD3+CD4+CD25+ T
cells. More experiments are needed to elucidate the dose-
dependent eﬀect of lactadherin on the development of
intestinal immunity.
Nakayama et al. [29] reported that composition of
microﬂora in artiﬁcially fed animals is diﬀerent from that in
mother fed animals, which might result in the diversity of T
subpopulations between the diﬀerently fed animals. Indeed,
we observed a signiﬁcant diﬀerence between AR group and
LR group pups. Whether this was due to either the pattern
of bacterial colonization, cannula implantation, lactadherin,
or the combination of these factors was not examined in our
study. Notably, the CD3+CD4+CD25+ expression was higher
in LR group than in AR group. As the rats of LR group and
AR group received the same treatment except lactadherin,
our result supported the role of lactadherin in the regulation
of intestinal DCs and T cells.6 Clinical and Developmental Immunology
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Figure 2: Flow cytometric analyses of CD3+CD4+CD25+T - c e l l si nP P so fe a c hg r o u pi nd i ﬀerent development stages (Mean±SD). In order
to investigate T cells proliferation and diﬀerentiation in three diﬀerently fed groups, we examined the phenotype of CD3+CD4+Tc e l l s
subpopulation in the PPs by assessing the relative proportions of CD3+CD4+CD25+T cells. The results showed that the group of LR rats had
a higher relative proportion of CD3+CD4+CD25+ Tc e l l si nP P s( bA :B Ra tW 3 ,B :A Ra tW 3 ,C :L Ra tW 3 ,D :B Ra tW 5 ,E :A Ra tW 5 ,F :L R
at W5, G: BR at W7, H: AR at W7, I: LR at W7, J: BR at W11, K:AR at W11, L: LR at W11). ∗P<. 05.Clinical and Developmental Immunology 7
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Figure 3: Levels of IL-12 and IL-10 production in lactadherin-present and -absent DC cultures (Means±SD). No signiﬁcant diﬀerences in
IL-12 production were observed with or without lactadherin present in the culture medium. However, IL-10 production was dramatically
increased when lactadherin was present in the culture medium compared to when it was absent.
Although the intestinal mucosal immune system is fully
developed after birth, the actual protective function of the
gut requires the antigen stimulation. It is interesting that the
numbers of OX62+CD4+SIRP+ DC and CD3+CD4+CD25+
T cells are signiﬁcantly (almost two times) higher in LR
pups than AR pups at 3 weeks after birth, indicating
that the mucosal immunity of the LR pups might be
strengthened more than that of the AR pups during the
suckling period. Lactadherin feeding promoted the subset
of OX62+CD4+SIRP+ DC and CD3+CD4+CD25+ Tc e l l so f
age week 3 rat pups; it was likely to be a consequence of
weaning [30], when the sharp increase in various types of
antigens occurred; lactadherin can be used as a dietary sup-
plement to stimulate the development of intestinal immune
system. In addition, even after weaning, the expressions of
CD3+CD4+CD25+ T cells and OX62+CD4+SIRP+ DCs were
detected at higher levels in LR pups than in MR and AR
pups. There is also a good evidence of continued protection
against medical condition for years after feeding in early
time. The molecular mechanism underlying this process
needs to be further elucidated. Another major ﬁnding of
the present study is that lactadherin aﬀected some cytokine
secretion in human cord blood monocyte-derived DCs. A
subpopulation of CD4+T cells that coexpresses CD25 (the
a-chain of IL-2R), which possesses regulatory functions, has
been identiﬁed in the mucosa and has been purported to be
generated by the exposure of the intestinal immune system
to luminal antigens. These cells appear to play an important
role in the induction and maintenance of tolerance in the
normal intestine [29]. As discussed earlier, CD3+ CD4+
CD25+ T-cells are potent immunosuppressors that control
or prevent the development of spontaneous autoimmune
diseases [30] and are involved in preventing intestinal IBD
[28]. To conﬁrm the present results, the cytokines IL-12 and
IL-10, which are produced by DCs in vitro, were detected
in the presence and absence of lactadherin. IL-10 is capable
of inhibiting the synthesis of proinﬂammatory cytokines,
while IL-12 is linked to autoimmunity by stimulating
the production of interferon-gamma (IFN-γ)a n dt u m o r
necrosis factor-alpha (TNF-α) from T and natural killer
(NK) cells, and by reducing IL-4-mediated suppression of
IFN-γ. This result showed that lactadherin enhanced DC
secretion of IL-10 indicates that lactadherin might modulate
intestinal allergy reactions. Additionally, the present study
also demonstrated the development of a subset of DCs
prior to the development of subsets of T cells. Therefore,
we assume that it is likely that the development of DC
subsets may drive T cells to assume distinct phenotypes
and functions, although direct stimulation of T cell activity
by lactadherin was ruled out. In summary, we observed
that lactadherin feeding-deﬁcient rats are characterized by a
fewer number of active DCs and Tregs, reminiscent of the
observations made regarding the poor immune function of
formula-fed infants, which are deﬁcient in some immune
component, including lactadherin.
5. Conclusion
In the study, the AR rat pups matured to the same degree
as MR and LR pups with respect to physical appearance.
However, there were great diﬀerences in the number of
OX62+ CD4+ SIRP+ DC and CD3+CD4+CD25+T cells
among the three groups. The number of OX62+CD4+SIRP+
DC and CD3+CD4+CD25+T cells in LR pups showed a
more similar pattern to that in the BR pups than in the AR
pups. Therefore, the diﬀerences observed between the BR
and AR group seemed to be the eﬀect of the formulation
of the milk rather than the eﬀect of artiﬁcial cannulation.
To our knowledge, this is the ﬁrst report showing an
association between lactadherin and the development of
intestinal development. Our ﬁnding supports the hypothesis8 Clinical and Developmental Immunology
that lactadherin could adjust intestinal DCs activity, induce
CD4+CD25+Tc e l ld i ﬀerentiation, and inhibit IL-10 pro-
duction. The molecular mechanism underlying this process
needs to be further elucidated.
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